본문 바로가기
KERD
논문KCI 등재

Stevens-Johnson Syndrome Following ChAdOx1 nCoV-19 Vaccination (AstraZeneca)

0

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류피부과학

초록

.

Abstract

.

참고문헌 (5)

  1. Ramasamy MN, "Safety and immunogenicity of ChAdOx1nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2", 3 trial, 2021, pp.396, 1978~
  2. Su JR, "Erythema multiforme, Stevens Johnson syndrome, and toxic epidermal necrolysis reported after vaccination, 1999-2017", Vaccine, 38, pp.1746~1752 (2020)
  3. Voysey M, "Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK", Lancet, 397, pp.99~111 (2021)
  4. Dash S, "COVID-19 vaccine-induced Stevens-Johnson syndrome", Clin Exp Dermatol, 46, pp.1615~1617 (2021)
  5. Lospinoso K, "A case of severe cutaneous adverse reaction following administration of the Janssen Ad26. COV2. S COVID-19 vaccine", JAAD Case Rep, 13, pp.134~137 (2021)

관련 논문AI추천

이 간행물의 다른 논문 (129건)